STALLERGENES GREER ANNOUNCES RESIGNATION OF CHIEF FINANCIAL OFFICER
January 31, 2017 – Stallergenes Greer plc (the “Company”), a biopharmaceutical company specializing in treatments for respiratory allergies, today announced that Peter Bühler has resigned as Chief Financial Officer. His last day will be April 28, 2017.
Mr. Bühler joined Stallergenes Greer in April 2013 and made the decision to leave the Company in order to move back to his home country of Switzerland to pursue other opportunities.
“I want to thank Peter for his contributions over the past four years. We wish him the best in his future endeavors," said Fereydoun Firouz, Chairman and Chief Executive Officer.
The Company has initiated an external search for a successor.